# Escalon Medical Corp (ESMC)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/escalon-medical-corp/ JSON: https://steadybase.io/company/escalon-medical-corp.json Checked Nov 10, 2026. Latest filing read: Oct 13, 2026.

## Company

- Legal name: ESCALON MEDICAL CORP
- Ticker: ESMC (OTC)
- SEC CIK: 0000862668
- Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Headquarters: Wayne, PA
- Fiscal year ends: June 30
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: escalonmed.com
- LinkedIn: https://www.linkedin.com/company/escalon-medical-corp
- Next earnings date: Nov 14, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $12.7M for the fiscal year ended Jun 30, 2026 (10-K filed Oct 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/0001628280-26-065683-index.html
- Operating income: $45,235 for the fiscal year ended Jun 30, 2026 (10-K filed Oct 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/0001628280-26-065683-index.html
- Net income: $4.0M for the fiscal year ended Jun 30, 2026 (10-K filed Oct 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/0001628280-26-065683-index.html
- SG&A: $5.0M for the fiscal year ended Jun 30, 2026 (10-K filed Oct 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/0001628280-26-065683-index.html
- Employees: 40 as of Jun 30, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- Shares outstanding: 7,415,329 as of Sep 25, 2026 (10-K filed Oct 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/0001628280-26-065683-index.html
- Auditor: Cbiz, Cpas P.C., Marlton, New Jersey, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm

## Business

Escalon Medical Corp. ("Escalon" or "Company") is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon, which includes its division called "Trek" and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Escalon Digital Solutions, Inc. (“EMI”), and Sonomed IP Holdings, Inc. All intercompany accounts and transactions have been eliminated.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Jun 30, 2026 | $12.7M | $45,235 | $4.0M | $5.0M |
| Jun 30, 2025 | $12.0M | $133,217 | $105,525 | $4.6M |
| Jun 30, 2024 | $12.0M | -$104,476 | -$125,261 | $4.6M |
| Jun 30, 2023 | $12.2M | $478,543 | $456,826 | $4.2M |
| Jun 30, 2022 | $10.7M | -$470,063 | $18,081 | $4.1M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/escalon-medical-corp.json

## Officers and directors

- Richard J. DePiano, Jr., Chairman and Chief Executive Officer (Principal Executive Officer). LinkedIn: https://linkedin.com/in/richard-depiano-jr-26b98211. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- Weiying Huang, Chief Financial Officer. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- Mark G. Wallace, Chief Operating Officer and Principal Financial & Accounting Officer. LinkedIn: https://linkedin.com/in/mark-wallace-45aaaa31. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- C. Todd Trusk, Director. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- David J. Jacovini, Director. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- John P. Dogum, Director. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- Lisa A. Napolitano, Director. Source: 10-K filed Oct 13, 2026, https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm

## Recent 8-K events

- Jan 29, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.01, Completion of acquisition or disposition of assets; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/862668/000121390026009497/ea0274379-8k_escalon.htm
- Apr 4, 2025: Item 4.01, Changes in registrant's certifying accountant; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/862668/000121390025028990/ea0237184-8k_escalon.htm
- Nov 2, 2022: Item 4.01, Changes in registrant's certifying accountant; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/862668/000121390022068665/ea167910-8k_escalon.htm
- Jul 6, 2018: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/862668/000086266818000012/final8kform.htm
- Feb 20, 2018: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/862668/000129993318000178/htm_55892.htm
- Feb 15, 2018: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 5.01, Changes in control of registrant; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/862668/000129993318000156/htm_55867.htm
- Jan 24, 2018: Item 4.01, Changes in registrant's certifying accountant. Source: https://www.sec.gov/Archives/edgar/data/862668/000129993318000081/htm_55783.htm
- Jul 7, 2017: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/862668/000129993317000689/htm_55124.htm
- Jul 6, 2017: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/862668/000129993317000687/htm_55122.htm
- Jan 5, 2017: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/862668/000129993317000014/htm_54452.htm

## Latest filings

- 8-K filed Jan 29, 2026: https://www.sec.gov/Archives/edgar/data/862668/000121390026009497/ea0274379-8k_escalon.htm
- 10-K filed Oct 13, 2026: https://www.sec.gov/Archives/edgar/data/862668/000162828026065683/esmc-20260630.htm
- 10-Q filed May 15, 2026: https://www.sec.gov/Archives/edgar/data/862668/000162828026035533/esmc-20260331.htm
- DEF 14A filed May 18, 2017: https://www.sec.gov/Archives/edgar/data/862668/000086266817000012/def14amay2017.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/